These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 11089525)
1. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Gilbert L; He X; Farmer P; Boden S; Kozlowski M; Rubin J; Nanes MS Endocrinology; 2000 Nov; 141(11):3956-64. PubMed ID: 11089525 [TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α. Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073 [TBL] [Abstract][Full Text] [Related]
5. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2. Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788 [TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Deckers MM; van Bezooijen RL; van der Horst G; Hoogendam J; van Der Bent C; Papapoulos SE; Löwik CW Endocrinology; 2002 Apr; 143(4):1545-53. PubMed ID: 11897714 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Suzawa M; Takeuchi Y; Fukumoto S; Kato S; Ueno N; Miyazono K; Matsumoto T; Fujita T Endocrinology; 1999 May; 140(5):2125-33. PubMed ID: 10218963 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells. Bunyaratavej P; Hullinger TG; Somerman MJ Exp Cell Res; 2000 Nov; 260(2):324-33. PubMed ID: 11035927 [TBL] [Abstract][Full Text] [Related]
12. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Yeh LC; Adamo ML; Olson MS; Lee JC Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928 [TBL] [Abstract][Full Text] [Related]
13. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Boden SD; Liu Y; Hair GA; Helms JA; Hu D; Racine M; Nanes MS; Titus L Endocrinology; 1998 Dec; 139(12):5125-34. PubMed ID: 9832452 [TBL] [Abstract][Full Text] [Related]
14. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. Harris SE; Bonewald LF; Harris MA; Sabatini M; Dallas S; Feng JQ; Ghosh-Choudhury N; Wozney J; Mundy GR J Bone Miner Res; 1994 Jun; 9(6):855-63. PubMed ID: 8079661 [TBL] [Abstract][Full Text] [Related]
15. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. Gilbert L; He X; Farmer P; Rubin J; Drissi H; van Wijnen AJ; Lian JB; Stein GS; Nanes MS J Biol Chem; 2002 Jan; 277(4):2695-701. PubMed ID: 11723115 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism. Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266 [TBL] [Abstract][Full Text] [Related]
17. Semi-quantitative RT-PCR analysis of LIM mineralization protein 1 and its associated molecules in cultured human dental pulp cells. Zhang Q; Wang X; Chen Z; Liu G; Chen Z Arch Oral Biol; 2007 Aug; 52(8):720-6. PubMed ID: 17368558 [TBL] [Abstract][Full Text] [Related]